2L4S

Promiscuous Binding at the Crossroads of Numerous Cancer Pathways: Insight from the Binding of GIP with Glutaminase L

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-15N HSQC	0.5-1 mM [U-99% 13C; U-99% 15N] Glutaminase Interacting Protein 3, 50 mM sodium phosphate, 0.1% w/v sodium azide, 1 mM EDTA	95% H2O/5% D2O	50	6.5	ambient	298
2	2D 1H-13C HSQC	0.5-1 mM [U-99% 13C; U-99% 15N] Glutaminase Interacting Protein 3, 50 mM sodium phosphate, 0.1% w/v sodium azide, 1 mM EDTA	95% H2O/5% D2O	50	6.5	ambient	298
3	3D CBCA(CO)NH	0.5-1 mM [U-99% 13C; U-99% 15N] Glutaminase Interacting Protein 3, 50 mM sodium phosphate, 0.1% w/v sodium azide, 1 mM EDTA	95% H2O/5% D2O	50	6.5	ambient	298
4	3D HNCACB	0.5-1 mM [U-99% 13C; U-99% 15N] Glutaminase Interacting Protein 3, 50 mM sodium phosphate, 0.1% w/v sodium azide, 1 mM EDTA	95% H2O/5% D2O	50	6.5	ambient	298
5	3D HNCO	0.5-1 mM [U-99% 13C; U-99% 15N] Glutaminase Interacting Protein 3, 50 mM sodium phosphate, 0.1% w/v sodium azide, 1 mM EDTA	95% H2O/5% D2O	50	6.5	ambient	298
6	3D HNCA	0.5-1 mM [U-99% 13C; U-99% 15N] Glutaminase Interacting Protein 3, 50 mM sodium phosphate, 0.1% w/v sodium azide, 1 mM EDTA	95% H2O/5% D2O	50	6.5	ambient	298
7	3D C(CO)NH	0.5-1 mM [U-99% 13C; U-99% 15N] Glutaminase Interacting Protein 3, 50 mM sodium phosphate, 0.1% w/v sodium azide, 1 mM EDTA	95% H2O/5% D2O	50	6.5	ambient	298
8	3D HN(CO)CA	0.5-1 mM [U-99% 13C; U-99% 15N] Glutaminase Interacting Protein 3, 50 mM sodium phosphate, 0.1% w/v sodium azide, 1 mM EDTA	95% H2O/5% D2O	50	6.5	ambient	298
9	3D H(CCO)NH	0.5-1 mM [U-99% 13C; U-99% 15N] Glutaminase Interacting Protein 3, 50 mM sodium phosphate, 0.1% w/v sodium azide, 1 mM EDTA	95% H2O/5% D2O	50	6.5	ambient	298
10	3D HCCH-TOCSY	0.5-1 mM [U-99% 13C; U-99% 15N] Glutaminase Interacting Protein 3, 50 mM sodium phosphate, 0.1% w/v sodium azide, 1 mM EDTA	95% H2O/5% D2O	50	6.5	ambient	298
11	3D HCCH-COSY	0.5-1 mM [U-99% 13C; U-99% 15N] Glutaminase Interacting Protein 3, 50 mM sodium phosphate, 0.1% w/v sodium azide, 1 mM EDTA	95% H2O/5% D2O	50	6.5	ambient	298
12	3D 1H-15N TOCSY	0.5-1 mM [U-99% 13C; U-99% 15N] Glutaminase Interacting Protein 3, 50 mM sodium phosphate, 0.1% w/v sodium azide, 1 mM EDTA	95% H2O/5% D2O	50	6.5	ambient	298
13	3D 1H-15N NOESY	0.5-1 mM [U-99% 13C; U-99% 15N] Glutaminase Interacting Protein 3, 50 mM sodium phosphate, 0.1% w/v sodium azide, 1 mM EDTA	95% H2O/5% D2O	50	6.5	ambient	298
14	3D 1H-13C NOESY	0.5-1 mM [U-99% 13C; U-99% 15N] Glutaminase Interacting Protein 3, 50 mM sodium phosphate, 0.1% w/v sodium azide, 1 mM EDTA	95% H2O/5% D2O	50	6.5	ambient	298

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE	600
2	Bruker	AVANCE	600
3	Bruker	AVANCE	600
4	Varian	INOVA	500

NMR Refinement
Method	Details	Software
DGSA-distance geometry simulated annealing		ARIA

NMR Ensemble Information
Conformer Selection Criteria	structures with the lowest energy
Conformers Calculated Total Number	200
Conformers Submitted Total Number	20
Representative Model	1 (lowest energy)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	data analysis	ARIA	1.1	Nilges, M. et al.
2	refinement	ARIA	1.1	Nilges, M. et al.

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.